GO:0015572 N-acetylglucosamine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015572 describes the molecular function that enables transfer of N-acetylglucosamine (GlcNAc) across a membrane, a step required for glycoprotein and glycoconjugate biosynthesis.
• The D isomer of N-acetylglucosamine is a common structural unit of glycoproteins in plants, bacteria and animals and is often the terminal sugar of an oligosaccharide group of a glycoprotein.
• Nucleotide-sugar transporters of the SLC35 family, such as SLC35A3, mediate UDP-N-acetylglucosamine/UMP antiport and are functionally and structurally related to GlcNAc transmembrane transport.
• SLC35G3 has been identified as a UDP-N-acetylglucosamine transporter required for sperm glycoprotein formation and male fertility in mice.
• Chitin synthase studies reveal how N-acetylglucosamine-containing polymers are transported and selectively inhibited, informing antimicrobial and antifungal strategies.
• Loss or modulation of N-acetylglucosamine transport affects N-glycosylation, cell-surface signaling and secretory pathway function, with implications for disease and infection.
Description
N-acetylglucosamine transmembrane transporter activity (GO:0015572) is a molecular function that enables the transfer of N-acetylglucosamine from one side of a membrane to the other. The D isomer of N-acetylglucosamine is a common structural unit of glycoproteins in plants, bacteria and animals and is often the terminal sugar of an oligosaccharide group of a glycoprotein. This transport step is essential because nucleotide-sugar and sugar substrates must be delivered to the correct membrane compartment for glycosylation reactions to proceed. Researchers study this activity to understand glycoprotein biosynthesis, cell-surface signaling and host-pathogen interactions. At the cellular level, N-acetylglucosamine transport is closely linked to the secretory pathway and to Golgi-resident nucleotide-sugar transporters such as SLC35A3, which catalyze UDP-N-acetylglucosamine/UMP antiport. Conserved residues including Glu-47 and Lys-50 are critical for this antiport activity, providing a structural basis for substrate recognition and transport. In mice, SLC35G3 functions as a UDP-N-acetylglucosamine transporter that supports sperm glycoprotein formation and male fertility, demonstrating a physiological requirement for N-acetylglucosamine transport in reproduction. Because N-acetylglucosamine is a terminal sugar of many glycoproteins, defects in its transport can alter N-glycosylation and cell-surface regulation. N-glycosylation acts as an adaptive regulator at the cell surface, influencing receptor behavior and signaling. In addition, EGF-like-domain-specific O-glycans depend on secretory pathway function, and retention of DLK1 in the endoplasmic reticulum highlights how glycosylation and transport defects can perturb protein trafficking. These connections make GO:0015572 a relevant node for studies of glycobiology, fertility, infection and cancer biology.
N-acetylglucosamine transmembrane transporter activity At A Glance
| GO ID | GO:0015572 |
|---|---|
| GO term | N-acetylglucosamine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | D-GlcNAc transmembrane transporter activity; N-acetylchitosamine transmembrane transporter activity; N-Acetyl-D-glucosamine permease; N-acetyl-D-glucosamine transmembrane transporter activity; N-acetylglucosamine permease activity |
| Major function | Enables transfer of N-acetylglucosamine from one side of a membrane to the other |
| Substrate | N-acetylglucosamine, with the D isomer being a common structural unit of glycoproteins |
| Biological context | Glycoprotein biosynthesis, oligosaccharide assembly and cell-surface regulation |
| Related transporters | SLC35A3 and SLC35G3 mediate UDP-N-acetylglucosamine transport in related pathways |
| Disease relevance | Fertility, glycosylation disorders, infection and cancer biology |
What Is GO:0015572?
GO:0015572, N-acetylglucosamine transmembrane transporter activity, is defined as enabling the transfer of N-acetylglucosamine from one side of a membrane to the other. The D isomer of N-acetylglucosamine is a common structural unit of glycoproteins in plants, bacteria and animals and is often the terminal sugar of an oligosaccharide group of a glycoprotein. Synonyms include D-GlcNAc transmembrane transporter activity, N-acetylchitosamine transmembrane transporter activity, N-Acetyl-D-glucosamine permease, N-acetyl-D-glucosamine transmembrane transporter activity and N-acetylglucosamine permease activity.
Why Is N-acetylglucosamine transmembrane transporter activity Important in Cell Biology?
GO:0015572 is important because N-acetylglucosamine is a fundamental building block of glycoproteins and glycoconjugates, and its transport across membranes determines whether glycosylation reactions can occur in the correct compartment. Nucleotide-sugar transporters such as SLC35A3 and SLC35G3 provide the supply route for UDP-N-acetylglucosamine, and their activity is required for processes ranging from sperm glycoprotein formation and male fertility to secretory pathway function. Because N-glycosylation acts as an adaptive regulator at the cell surface, changes in N-acetylglucosamine transport can influence receptor signaling and cellular responses. In pathogens, N-acetylglucosamine-containing polymers such as chitin are essential, and selective inhibition of chitin synthase highlights the therapeutic potential of targeting this sugar pathway. Together, these findings make GO:0015572 a key functional node for glycobiology, reproductive biology, infection and cancer research.
• Provides the membrane transport step required for N-acetylglucosamine to participate in glycoprotein and oligosaccharide biosynthesis.
• Supports sperm glycoprotein formation and male fertility through SLC35G3-mediated UDP-N-acetylglucosamine transport in mice.
• Underpins Golgi-resident UDP-N-acetylglucosamine/UMP antiport by SLC35A3, with conserved Glu-47 and Lys-50 residues critical for activity.
• Links to N-glycosylation, which acts as an adaptive regulator at the cell surface and influences signaling.
• Affects secretory pathway function, as shown by EGF-like-domain-specific O-glycans and DLK1 retention in the endoplasmic reticulum.
• Is relevant to infection biology because chitin synthase uses N-acetylglucosamine-containing substrates and can be selectively inhibited.
• Provides a potential target for modulating glycoprotein production in biotechnology and therapeutic protein manufacturing.
• Connects to porcine SLC35A3 expression, chromosome assignment and mutational analysis, informing comparative and agricultural genomics.
• Offers a handle for studying post-antibiotic effect modulators and antimicrobial strategies.
• Enables mechanistic dissection of sugar transport in reproduction, development and disease.
Molecular Mechanism of N-acetylglucosamine transmembrane transporter activity
Substrate recognition and binding
In simple terms: The transporter must first recognize and grab N-acetylglucosamine before it can move it across the membrane.
N-acetylglucosamine transmembrane transporter activity enables the transfer of N-acetylglucosamine from one side of a membrane to the other, and the D isomer is a common structural unit of glycoproteins in plants, bacteria and animals. In related nucleotide-sugar transport, conserved residues such as Glu-47 and Lys-50 are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3, indicating that specific amino acids form the substrate-binding and catalytic core. These findings suggest that N-acetylglucosamine recognition depends on a defined binding pocket within the transporter.
Translocation across the membrane
In simple terms: Once bound, the sugar is moved through the transporter from one side of the membrane to the other.
The defining catalytic event of GO:0015572 is the transfer of N-acetylglucosamine across a membrane. SLC35G3 functions as a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation, demonstrating that N-acetylglucosamine-bearing substrates must be translocated to support glycoprotein biosynthesis. Chitin synthase studies further show that N-acetylglucosamine-containing polymers are transported and assembled, and that this process can be selectively inhibited. Together, these observations support a model in which substrate binding is followed by a conformational change that moves the sugar across the lipid bilayer.
Antiport and coupling to nucleotide-sugar exchange
In simple terms: Some transporters swap one molecule for another across the membrane, coupling sugar import to waste-product export.
SLC35A3 mediates UDP-N-acetylglucosamine/UMP antiport activity, and conserved Glu-47 and Lys-50 residues are critical for this exchange. Porcine SLC35A3 is a Golgi-resident UDP-N-acetylglucosamine transporter whose gene expression, chromosome assignment and mutations have been characterized, providing comparative evidence for conserved antiport function. This antiport mechanism ensures that N-acetylglucosamine-bearing nucleotide sugars are supplied to the Golgi lumen while the corresponding nucleoside monophosphate is returned.
Delivery to glycosylation machinery
In simple terms: After transport, the sugar is handed off to enzymes that build glycoproteins and oligosaccharides.
N-acetylglucosamine is often the terminal sugar of an oligosaccharide group of a glycoprotein, so its delivery to the correct compartment is essential for glycoprotein maturation. SLC35G3-dependent UDP-N-acetylglucosamine transport supports sperm glycoprotein formation and male fertility in mice, linking transport directly to glycoprotein assembly. EGF-like-domain-specific O-glycans and DLK1 retention in the endoplasmic reticulum further show that glycosylation and secretory pathway function are tightly connected to sugar transport. N-glycosylation at the cell surface acts as an adaptive regulator, so delivery of N-acetylglucosamine influences signaling outcomes.
Regulation and inhibition
In simple terms: Transport activity can be turned up, down or blocked, which changes how much glycoprotein cells can make.
Chitin synthase can be selectively inhibited, demonstrating that N-acetylglucosamine-containing polymer assembly is a druggable process. Modulators of the post-antibiotic effect have been identified, indicating that sugar transport and cell-wall-related pathways can be targeted pharmacologically. Adaptive regulation at the cell surface by N-glycosylation provides a feedback context in which transport activity and glycosylation status influence each other. These layers of regulation make GO:0015572 a dynamic function rather than a fixed housekeeping step.
Key Genes Involved in GO:0015572 N-acetylglucosamine transmembrane transporter activity
The following genes and proteins are functionally or mechanistically linked to N-acetylglucosamine transmembrane transporter activity and its related nucleotide-sugar transport pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC35G3 | UDP-N-acetylglucosamine transporter for sperm glycoprotein formation | Male fertility and sperm glycoprotein biology |
| SLC35A3 | Golgi-resident UDP-N-acetylglucosamine/UMP antiporter | Conserved antiport mechanism and mutational analysis |
| SLC35A3 (porcine) | Golgi-resident UDP-N-acetylglucosamine transporter | Gene expression profiling, chromosome assignment and mutation studies |
| Chitin synthase | Catalyzes N-acetylglucosamine polymer synthesis and transport | Antifungal and antimicrobial target studies |
| DLK1 | Secretory pathway protein affected by O-glycan status | Endoplasmic reticulum retention and trafficking studies |
| N-glycosylation machinery | Cell-surface adaptive regulation | Glycoprotein and signaling research |
| UDP-N-acetylglucosamine pool enzymes | Supply substrate for transport | Metabolic and flux studies |
| Golgi apparatus transporters | Deliver nucleotide sugars to lumen | Organelle transport research |
| Sperm glycoprotein components | Require UDP-N-acetylglucosamine transport | Reproductive biology |
| Post-antibiotic effect modulators | Influence sugar-related pathways | Antibiotic persistence research |
| O-glycan transferases | Modify EGF-like domains | Secretory pathway research |
| N-acetylglucosamine permease | Transports N-acetylglucosamine across membranes | Functional annotation and transport assays |
| D-GlcNAc transporter | Transports the D isomer of N-acetylglucosamine | Glycobiology research |
| N-acetylchitosamine transporter | Synonym for N-acetylglucosamine transport | Ontology and annotation studies |
| N-Acetyl-D-glucosamine permease | Synonym for N-acetylglucosamine transport | Microbial transport studies |
How Is N-acetylglucosamine transmembrane transporter activity Regulated?
N-acetylglucosamine transmembrane transporter activity is regulated at multiple levels. Adaptive regulation at the cell surface by N-glycosylation provides a feedback mechanism in which glycosylation status influences cell-surface behavior. Conserved residues such as Glu-47 and Lys-50 are critical for UDP-N-acetylglucosamine/UMP antiport activity, so mutations in these positions can directly alter transport capacity. SLC35G3-dependent UDP-N-acetylglucosamine transport is required for sperm glycoprotein formation, indicating developmental and tissue-specific regulation. Selective inhibition of chitin synthase shows that N-acetylglucosamine-containing polymer assembly can be pharmacologically modulated. Modulators of the post-antibiotic effect further suggest that sugar transport pathways respond to environmental and antibiotic stress. Together, these findings indicate that GO:0015572 is regulated by substrate availability, protein sequence determinants, tissue context and pharmacological perturbation.
N-acetylglucosamine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC35G3 | Male fertility and sperm glycoprotein formation | Knockout mouse and sperm glycoprotein analysis |
| SLC35A3 | Golgi UDP-N-acetylglucosamine/UMP antiport and glycosylation | Point mutation of Glu-47 and Lys-50 |
| Chitin synthase | Infection and antifungal targeting | Selective inhibition assays |
| DLK1 | Secretory pathway and O-glycan-dependent trafficking | Endoplasmic reticulum retention models |
| N-glycosylation machinery | Cell-surface adaptive regulation and signaling | Glycosylation profiling and signaling assays |
Male fertility and reproductive disorders
SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice. Loss of this transport function impairs sperm glycoprotein formation, linking GO:0015572-related activity to reproductive disorders. These findings suggest that N-acetylglucosamine transport should be evaluated in cases of unexplained male infertility.
Glycosylation disorders and secretory pathway disease
N-acetylglucosamine is often the terminal sugar of an oligosaccharide group of a glycoprotein, so defective transport can perturb glycoprotein maturation. EGF-like-domain-specific O-glycans and DLK1 retention in the endoplasmic reticulum show that glycosylation defects can cause protein trafficking abnormalities. N-glycosylation acts as an adaptive regulator at the cell surface, so altered transport may contribute to signaling-related disease phenotypes.
Infection and antimicrobial resistance
Chitin synthase uses N-acetylglucosamine-containing substrates, and selective inhibition of this enzyme is a validated antimicrobial strategy. Modulators of the post-antibiotic effect have been identified, indicating that sugar-related pathways influence antibiotic responses. These observations connect GO:0015572-related transport to infection biology and drug development.
Cancer and cell-surface signaling
N-glycosylation at the cell surface acts as an adaptive regulator, and changes in glycosylation are associated with altered receptor signaling. Because N-acetylglucosamine transport supplies substrates for glycosylation, its dysfunction may influence cancer cell-surface phenotypes. Comparative studies of SLC35A3 expression and mutations provide a framework for evaluating transport genes in disease.
From N-acetylglucosamine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of N-acetylglucosamine transport impair fertility? | SLC35G3 knockout mouse |
| Which residues are required for UDP-N-acetylglucosamine/UMP antiport? | SLC35A3 point mutation at Glu-47 and Lys-50 |
| Can N-acetylglucosamine transport be redirected to a specific compartment? | Knock-in of tagged transporter |
| Does overexpression of a transporter increase glycoprotein output? | Overexpression cell model |
| How does transport inhibition affect infection? | Chitin synthase inhibition assays |
| What signaling pathways respond to altered glycosylation? | N-glycosylation perturbation and cell-surface assays |
How to Study the N-acetylglucosamine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transport assay | Movement of N-acetylglucosamine across membranes | Functional annotation of transporters |
| Antiport assay | UDP-N-acetylglucosamine/UMP exchange | SLC35A3 mechanism studies |
| Glycoprotein profiling | Glycan composition and terminal sugars | Glycosylation disorder research |
| Mutational analysis | Residue requirements for transport | Structure-function studies |
| Gene expression profiling | Transcript levels of transporter genes | Comparative genomics |
| Knockout models | Physiological requirement for transport | Fertility and development studies |
| Inhibition assays | Sensitivity of N-acetylglucosamine polymer synthesis | Antimicrobial discovery |
| Post-antibiotic effect screening | Modulators of antibiotic persistence | Infection biology |
Transport assays
Direct measurement of N-acetylglucosamine transmembrane transporter activity requires assays that track substrate movement across membranes. Related nucleotide-sugar transport studies use UDP-N-acetylglucosamine/UMP antiport readouts to quantify SLC35A3 activity and the contribution of conserved residues. Chitin synthase studies provide complementary assays for N-acetylglucosamine-containing polymer transport and inhibition.
Glycoprotein and glycan profiling
Because N-acetylglucosamine is often the terminal sugar of an oligosaccharide group of a glycoprotein, glycan profiling is a key method for assessing transport function. Sperm glycoprotein formation in SLC35G3 models can be evaluated by glycoprotein analysis. EGF-like-domain-specific O-glycans and DLK1 trafficking provide additional readouts for secretory pathway glycosylation.
Genetic and mutational analysis
Mutational analysis of SLC35A3 has identified Glu-47 and Lys-50 as critical for UDP-N-acetylglucosamine/UMP antiport activity. Porcine SLC35A3 gene expression profiling, chromosome assignment and mutational analysis provide a comparative framework for transport gene studies. Knockout and knock-in models can test causality of transport genes in physiological processes.
Pharmacological modulation
Selective inhibition of chitin synthase demonstrates that N-acetylglucosamine-related transport and polymerization can be pharmacologically targeted. Modulators of the post-antibiotic effect can be screened to identify compounds that influence sugar-related pathways. These approaches are useful for antimicrobial and glycobiology drug discovery.
How CRISPR Can Be Used to Study GO:0015572 N-acetylglucosamine transmembrane transporter activity
Knockout
CRISPR knockout of SLC35G3 or SLC35A3 can test whether N-acetylglucosamine transmembrane transporter activity is required for sperm glycoprotein formation, glycosylation and fertility. Knockout models provide causal evidence linking GO:0015572 to physiological outcomes.
Point Mutation
Point mutation of conserved residues such as Glu-47 and Lys-50 in SLC35A3 can dissect the catalytic requirements for UDP-N-acetylglucosamine/UMP antiport activity. Such models help distinguish substrate binding from translocation.
Knock-in
Knock-in of tagged transporters allows localization and trafficking studies of N-acetylglucosamine transport proteins in the secretory pathway. Tagged knock-in can also enable purification and interaction studies.
Overexpression
Overexpression of N-acetylglucosamine transporters can increase substrate supply for glycosylation and test whether glycoprotein output is transport-limited. Overexpression models are useful for biotechnology and glycoprotein production research.
How EDITGENE Supports N-acetylglucosamine transmembrane transporter activity Research
Researchers studying N-acetylglucosamine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, fertility or infection phenotypes. EDITGENE provides CRISPR-based cell models and screening services that enable precise interrogation of GO:0015572-related genes such as SLC35G3 and SLC35A3.
Contact EDITGENE today to design your custom CRISPR model for N-acetylglucosamine transmembrane transporter activity research.
Frequently Asked Questions About N-acetylglucosamine transmembrane transporter activity
What is N-acetylglucosamine transmembrane transporter activity?
It is a molecular function, GO:0015572, that enables the transfer of N-acetylglucosamine from one side of a membrane to the other, with the D isomer being a common structural unit of glycoproteins.
What genes are involved in N-acetylglucosamine transmembrane transporter activity?
Genes and proteins linked to this activity include SLC35G3, SLC35A3, chitin synthase and components of the N-glycosylation machinery.
What is the GO ID for N-acetylglucosamine transmembrane transporter activity?
The GO ID is GO:0015572.
What are the synonyms for GO:0015572?
Synonyms include D-GlcNAc transmembrane transporter activity, N-acetylchitosamine transmembrane transporter activity, N-Acetyl-D-glucosamine permease, N-acetyl-D-glucosamine transmembrane transporter activity and N-acetylglucosamine permease activity.
Why is N-acetylglucosamine transport important for fertility?
SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice.
How is N-acetylglucosamine transport related to glycosylation?
N-acetylglucosamine is often the terminal sugar of an oligosaccharide group of a glycoprotein, so its transport supplies substrates for glycoprotein maturation.
Which residues are critical for UDP-N-acetylglucosamine/UMP antiport?
Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3.
Can N-acetylglucosamine transport be targeted for antimicrobial therapy?
Chitin synthase, which uses N-acetylglucosamine-containing substrates, can be selectively inhibited, supporting antimicrobial targeting strategies.
What experimental models are used to study GO:0015572?
Models include SLC35G3 knockout mice, SLC35A3 point mutations, tagged knock-in transporters, overexpression cell models and inhibition assays.
How does N-glycosylation regulate cell-surface behavior?
N-glycosylation acts as an adaptive regulator at the cell surface, influencing receptor behavior and signaling.
Conclusion
GO:0015572, N-acetylglucosamine transmembrane transporter activity, is a central molecular function for delivering N-acetylglucosamine across membranes to support glycoprotein and oligosaccharide biosynthesis. Studies of SLC35G3 and SLC35A3 have revealed conserved transport mechanisms, critical residues and physiological roles in fertility and glycosylation. Related work on chitin synthase and post-antibiotic effect modulators highlights the therapeutic potential of targeting N-acetylglucosamine-related pathways. Researchers can now use CRISPR knockout, point mutation, knock-in and overexpression models to dissect how this transport activity contributes to glycosylation, signaling and disease. EDITGENE provides these models and screening services to accelerate functional studies of N-acetylglucosamine transmembrane transporter activity and its associated genes.
References
- 1. Mashiko D et al.. 2025. SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice.. Elife 14 PMID: 41222000
- 2. Toscanini MA et al.. 2019. Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3.. J Biol Chem 294(26):10042-10054 PMID: 31118275
- 3. Mashiko D et al.. 2025. SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice.. bioRxiv PMID: 40462929
- 4. Gilberti AL et al.. 2025. Identifying Modulators of the Post-Antibiotic Effect.. ACS Infect Dis 11(9):2542-2552 PMID: 40767145
- 5. Dennis JW et al.. 2009. Adaptive regulation at the cell surface by N-glycosylation.. Traffic 10(11):1569-78 PMID: 19761541
- 6. Andersen PK et al.. 2007. Gene expression profiling, chromosome assignment and mutational analysis of the porcine Golgi-resident UDP-N-acetylglucosamine transporter SLC35A3.. Mol Membr Biol 24(5-6):519-30 PMID: 17710655
- 7. Tashima Y et al.. 2025. Retention of DLK1 in the endoplasmic reticulum identifies roles for EGF-like-domain-specific O-glycans in the secretory pathway.. FEBS J 292(20):5355-5381 PMID: 40637009
- 8. Chen DD et al.. 2023. Structure, catalysis, chitin transport, and selective inhibition of chitin synthase.. Nat Commun 14(1):4776 PMID: 37553334
